1 |
Chan, L., O. Pereira, T. J. Reddy, S. K. Das, C. Poisson, M. Courchesne, M. Proulx, A. Siddiqui, C. G. Yannopoulos, et al. 2004. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: Tertiary amides. Bioorg. Med. Chem. Lett. 14: 797-800
DOI
ScienceOn
|
2 |
De Francesco, R. and G. Migliaccio. 2005. Challenges and successes in developing new therapies for hepatitis C. Nature 436: 953-960
DOI
ScienceOn
|
3 |
Gowans, E. J., K. L. Jones, M. Bharadwaj, and C. C. Jackson. 2004. Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J. Clin. Virol. 30: 283-290
DOI
ScienceOn
|
4 |
Hantusch, B., S. Krieger, E. Untersmayr, I. Scho, R. Knittelfelder, S. Flicker, S. Spitzauer, R. Valenta, G. Boltz-Nitulescu, et al. 2004. Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library. J. Allergy Clin. Immunol. 114: 1294-1300
DOI
ScienceOn
|
5 |
Lee, J.-H., I. Y. Nam, and H. Myung. 2006. Nonstructural protein 5B of hepatitis C virus. Mol. Cells 21: 330-336
|
6 |
McHutchison, J. G. and T. Poynard. 1999. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin. Liver Dis. 19: 57-65
|
7 |
Moradpour, D. and H. E. Blum. 2004. A primer on the molecular virology of hepatitis C. Liver Int. 24: 519-525
DOI
|
8 |
Purcell, R. 1994. Hepatitis viruses: Changing patterns of human disease. Proc. Natl. Acad. Sci. USA 91: 2401-2406
|
9 |
Seo, M., J. Lee, M. Kim, H. Chae, and H. Myung. 2006. Selection and characterization of peptides specifically binding to $ $ nanoparticles. J. Microbiol. Biotechnol. 16: 303-307
과학기술학회마을
|
10 |
Shin, K., J. Lim, J. Kim, H. Myung, and S.-W. Lee. 2006. Inhibition of replication of hepatitis C virus replicon with nuclease-resistant RNA aptamers. J. Microbiol. Biotechnol. 16: 1634-1639
과학기술학회마을
|
11 |
Tomei, L., S. Altamura, L. Bartholomew, M. Bisbocci, C. Bailey, M. Bosserman, A. Cellucci, E. Forte, I. Incitti, et al. 2004. Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides. J. Virol. 78: 938-946
DOI
ScienceOn
|
12 |
Wasley, A. and M. J. Alter. 2000. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin. Liver Dis. 20: 1-16
DOI
ScienceOn
|
13 |
Bressanelli, S., L. Tomei, A. Roussel, I. Incitti, R. L. Vitale, M. Mathieu, R. De Francesco, and F. A. Rey. 1999. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Natl. Acad. Sci. USA 96: 13034-13039
|
14 |
Rowley, M. J., M. Scealy, J. C. Whisstock, J. A. Jois, L. C. Wijeyewickrema, and I. R. Mackay. 2000. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J. Immunol. 164: 3413-3419
DOI
|
15 |
Leveque, V. J.-P. and Q. M. Wang. 2002. RNA-dependent RNA polymerase encoded by hepatitis C virus: Biomedical applications. Cell. Mol. Life Sci. 59: 909-919
DOI
ScienceOn
|
16 |
Nguyen, T. T., A. T. Gates, L. L. Gutshall, V. K. Johnston, B. Gu, K. J. Duffy, and R. T. Sarisky. 2003. Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor. Antimicrob. Agents Chemother. 47: 3525-3530
DOI
ScienceOn
|
17 |
Adachi, T., H. Ago, N. Habuka, K. Okuda, M. Komatsu, S. Ikeda, and K. Yatsunami. 2002. The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNAdependent RNA polymerase. Biochim. Biophys. Acta 1601: 38-48
DOI
ScienceOn
|
18 |
Smith, G. P. 1985. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228: 1315-1317
DOI
|
19 |
Wang, C., P. Sarnow, and A. Siddiqui. 1993. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67: 3338-3344
|
20 |
Wang, M., K. K. Ng, M. M. Cherney, L. Chan, C. G. Yannopoulos, J. Bedard, N. Morin, N. Nguyen-Ba, M. H. Alaoui-ismaili, et al. 2003. Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition. J. Biol. Chem. 278: 9489-9495
DOI
ScienceOn
|
21 |
Pogam, S. L., H. Kang, S. F. Harris, V. Leveque, A. M. Giannetti, S. Ali, W.-R. Jiang, S. Rajyaguru, G. Tavares, et al. 2006. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus. J. Virol. 80: 6146-6154
DOI
ScienceOn
|
22 |
Sidhu, S., W. Fairbrother, and K. Deshayes. 2003. Exploring protein-protein interactions with phage display. ChemBioChem 4: 14-25
DOI
ScienceOn
|
23 |
Tomei, L., S. Altamura, L. Bartholomew, A. Biroccio, A. Ceccacci, L. Pacini, F. Narjes, N. Gennari, M. Bisbocci, et al. 2003. Mechanism of action and antiviral activity of benzimidazolebased allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 77: 13225-13231
DOI
ScienceOn
|
24 |
Cohen, J. 1999. The scientific challenge of hepatitis C. Science 258: 26-30
|
25 |
Kim, J., H. Park, K. Choi, J. Lee, J. Park, and M. Yoon. 2006. Screening of peptides bound to anthrax protective antigen by phage display. J. Microbiol. Biotechnol. 16: 1784-1790
과학기술학회마을
|
26 |
Adda, C. G., R. F. Anders, L. Tilley, and M. Foley. 2002. Random sequence libraries displayed on phage: Identification of biologically important molecules. Comb. Chem. High Throughput Screen. 5: 1-14
DOI
ScienceOn
|
27 |
Rasmusen, U. B., V. Schreiber, H. Schultz, F. Mischler, and K. Schughart. 2002. Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther. 9: 606-612
DOI
ScienceOn
|
28 |
Yang, Z., W. Shm, M. Kim, K. Lee, K. Kim, K. Kim, C. Kim, S. Ha, and D. Chung. 2007. Production and characterization of monoclonal and recombinant antibodies against antimicrobial sulfamethazine. J. Microbiol. Biotechnol. 17: 571-578
과학기술학회마을
|
29 |
Suzuki, R., T. Suzuki, K. Ishii, Y. Matsuura, and T. Miyamura. 1999. Processing and functions of hepatitis C virus proteins. Intervirology 42: 145-152
DOI
ScienceOn
|
30 |
Hwang, B. and S.-W. Lee. 2005. Analysis of in vivo interaction of HCV NS3 protein and specific RNA aptamer with yeast three-hybrid system. J. Microbiol. Biotechnol. 15: 660-664
과학기술학회마을
|
31 |
Lecut, C., V. Arocas, H. Ulrichts, A. Elbaz, J. Villeval, J. Lacapere, H. Deckmyn, and M. Jandrot-Perrus. 2004. Identification of residues within human glycoprotein VI involved in the binding to collagen. J. Biol. Chem. 279: 52293-52299
DOI
ScienceOn
|
32 |
Ichii, K., Y. Tanaka, C.-C. Yap, H. Aizaki, Y. Matsumura, and T. Miyamura. 1999. Expression of hepatitis C virus NS5B protein: Characterization of its RNA polymerase activity and RNA binding. Hepatology 29: 1227-1235
DOI
ScienceOn
|
33 |
Beaulieu, P. L. and Y. S. Tsantrizos. 2004. Inhibitors of the HCV NS5B polymerase: New hope for the treatment of hepatitis C infections. Curr. Opin. Investig. Drugs 5: 838-850
|
34 |
Krieger, N., V. Lohmann, and R. Bartenschlager. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75: 4614-4624
DOI
ScienceOn
|
35 |
Kofler, M., K. Motzny, M. Beyermann, and C. Freund. 2005. Novel interaction partners of the CD2BP2-GYF domain. J. Biol. Chem. 280: 33397-33402
DOI
ScienceOn
|
36 |
Bressanelli, S., L. Tomei, F. A. Rey, and R. De Francesco. 2002. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J. Virol. 76: 3482-3492
DOI
ScienceOn
|
37 |
Lohmann, V., A. Roos, F. Korner, J.-O. Koch, and R. Bartenschlager. 2000. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J. Viral Hepat. 7: 167-174
DOI
ScienceOn
|
38 |
Amin, A., J. Zaccardi, S. Mullen, S. Olland, M. Orlowski, B. Feld, P. Labonte, and P. Mak. 2003. Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase. Virology 15: 158-169
|